Interferon-stimulated gene TDRD7 interacts with AMPK and inhibits its activation to suppress viral replication and pathogenesis

mBio. 2023 Oct 31;14(5):e0061123. doi: 10.1128/mbio.00611-23. Epub 2023 Sep 15.

Abstract

Virus infection triggers induction of interferon (IFN)-stimulated genes (ISGs), which ironically inhibit viruses themselves. We identified Tudor domain-containing 7 (TDRD7) as a novel antiviral ISG, which inhibits viral replication by interfering with autophagy pathway. Here, we present a molecular basis for autophagy inhibitory function of TDRD7. TDRD7 interacted with adenosine monophosphate (AMP)-activated protein kinase (AMPK), the kinase that initiates autophagy, to inhibit its activation. We identified domains required for the interaction; deleting AMPK-interacting domain blocked antiAMPK and antiviral activities of TDRD7. We used primary cells and mice to evaluate the TDRD7-AMPK antiviral pathway. TDRD7-deficient primary mouse cells exhibited enhanced AMPK activation and viral replication. Finally, TDRD7 knockout mice showed increased susceptibility to respiratory virus infection. Therefore, our study revealed a new antiviral pathway of IFN and its contribution to host response. Our results have therapeutic potential; a TDRD7-derived peptide may be an effective AMPK inhibitor with application as antiviral agent.

Keywords: AMPK; ISGs; Innate immunity; TDRD7; autophagy; herpesvirus; interferon; paramyxovirus.

MeSH terms

  • AMP-Activated Protein Kinases / metabolism
  • Animals
  • Antiviral Agents / pharmacology
  • Immunity, Innate
  • Interferons* / metabolism
  • Mice
  • Ribonucleoproteins / genetics
  • Virus Diseases*
  • Virus Replication / genetics

Substances

  • Interferons
  • AMP-Activated Protein Kinases
  • Antiviral Agents
  • TDRD7 protein, mouse
  • Ribonucleoproteins